ImmunoPrecise Antibodies

March 19, 2020

Hope replaces hype for coronavirus stocks

Investors are homing in on biopharma companies able to make real contributions to the coronavirus pandemic, but market frothiness is far from over.

March 05, 2020

Biopharma’s role in tackling coronavirus

The industry has a duty to develop Covid-19 antivirals and vaccines, but the nature of clinical trials means that lower-profile measures must take precedence.

February 27, 2020

Coronavirus stock hype proves infectious

Coronavirus-focused investors have willingly backed bona fide development and egregious publicity stunts alike.

ImmunoPrecise Antibodies

Hope replaces hype for coronavirus stocks

Biopharma’s role in tackling coronavirus

Coronavirus stock hype proves infectious

Latest Reports

Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2020

Evaluate Vantage COVID-19 Report

Editor's Picks

Esmo 2020 preview – late-breaking immunotherapy

Esmo 2020 preview – a kidney cancer showdown gets star billing

Big pharma spinouts grow up

Covid vaccine developers face nervous wait

Medtechs that book the most sales per employee face the greatest losses